Company Info

Company Info

RATIO ANALYSIS

Saroja Pharma Industries India Ltd.

You can view the ratio analysis for the last 5 years.
GO

NSE

Dec 16, 03:31
43.05 +0.00 (+ 0.00%)
Volume 0
Prev. Close 43.05
Open Price 0.00
Today's Low / High
0.00
     
0.00
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
34.00
     
61.95
ISIN No INE0PCL01011 Market Cap. ( in Cr. ) 17.31 P/BV 1.18 Book Value ( ) 36.42
BSE Code - 52 Week High/Low ( ) 62/34 FV/ML 10/1600 P/E(X) 16.74
NSE Code SAROJASM Book Closure 30/09/2024 EPS ( ) 2.57 Div Yield (%) 0.00
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)2.572.4917.5568.72731.30
Diluted EPS (Rs.)2.572.4917.5568.72731.30
Cash EPS (Rs.)2.862.423.8452.51753.66
Book Value[Excl.RevalReserv]/Share (Rs.)38.9936.4217.33178.28935.94
Book Value[Incl.RevalReserv]/Share (Rs.)38.9936.4217.33178.28935.94
Revenue From Operations / Share (Rs.)133.63101.15170.972463.5636661.54
PBDIT / Share (Rs.)7.396.839.80107.441347.96
PBIT / Share (Rs.)7.116.609.57105.421325.60
PBT / Share (Rs.)3.603.005.0869.941035.46
Net Profit / Share (Rs.)2.572.183.6150.49731.30
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)5.536.755.734.363.67
PBIT Margin (%)5.326.525.594.273.61
PBT Margin (%)2.692.962.972.832.82
Net Profit Margin (%)1.922.152.112.041.99
Return on Networth / Equity (%)6.595.9920.8528.3178.13
Return on Capital Employeed (%)16.7515.3635.5241.57141.36
Return On Assets (%)2.613.304.977.358.89
Long Term Debt / Equity (X)0.080.170.550.420.00
Total Debt / Equity (X)0.600.392.001.523.22
Asset Turnover Ratio (%)1.631.702.724.695.62
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.211.891.201.541.12
Quick Ratio (X)1.211.850.911.491.03
Inventory Turnover Ratio (X)216.5519.0822.0386.080.00
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)2.111.902.183.034.65
Interest Coverage Ratio (Post Tax) (%)1.731.611.802.423.52
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)24.3019.530.000.000.00
EV / Net Operating Revenue (X)0.450.480.000.000.00
EV / EBITDA (X)8.187.110.000.000.00
MarketCap / Net Operating Revenue (X)0.280.340.000.000.00
Price / BV (X)0.960.960.000.000.00
Price / Net Operating Revenue (X)0.280.340.000.000.00
EarningsYield0.060.060.000.000.00